Healthcare Provider Knowledge and Utilization of the Medicare Therapeutic Shoe Benefit
Journal of the American Podiatric Medical Association · 20.05.2026 · 116 (3) · 32
DOI: 10.3390/japma116030032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Podiatric Medical Association, online erschienen am 20.05.2026. Verfasst von Carol Szmuilowicz Kurth und 1 weiteren Autor:innen. Beteiligte Einrichtung: UCSF Stanyan Hospital Podiatry Residency Program, San Francisco, CA 94117, USA. Hauptthemen laut MEDLINE: Shoes, Diabetic Foot, Medicare, Health Personnel. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Podiatric Medical Association, American Podiatric Medical Student Association.
Abstract (Originalsprache)
The Therapeutic Shoe Benefit (TSB) allows Medicare insurance beneficiaries to reduce their diabetic foot ulcer risk by providing offloading shoes. Anecdotal evidence suggests that the process is cumbersome and that not all providers are aware of this benefit. This study evaluated TSB awareness across multiple healthcare disciplines and documented barriers to utilization. An online study surveyed healthcare providers practicing in the United States to determine familiarity with TSB and barriers to prescribing therapeutic shoes. The project was IRB-reviewed and received exempt status. The survey was sent to a wide variety of healthcare practitioners including: podiatrists, primary care providers, physical therapists, orthotist/prosthetists, specialty providers, and diabetes educators. This was done through targeted emails from professional organizations, word-of-mouth messaging through private practice groups, and marketing on LinkedIn. The survey was administered via Qualtrics with embedded branching logic used to gather data from the TSB’s three classifications of healthcare specialists: certifying physicians, prescribing practitioners, and suppliers. A total of 580 valid completions of the survey were analyzed. Irrespective of the TSB, podiatric physicians and medical professionals providing direct patient care recommend supportive shoes for patients with diabetes 98.2% (336/342) of the time. When asked about knowledge of the TSB, 522 or 90% of respondents indicated awareness of this Medicare benefit. Knowledge by specialty was hard to differentiate due to low responses by some specialties; however, prescribing podiatrists and prosthetic providers both responded with a familiarity rate above 92%. Common obstacles to providers prescribing shoes were: complexity of documentation (67.8%), challenges communicating with other providers (55.0%), and financial reasons/labor-to-reimbursement ratio (38.4%). TSB has the potential to reduce amputations and wound care costs. However, therapeutic shoes are underutilized with less than 20% of potential beneficiaries accessing this benefit. This research strengthens the argument that streamlining the process may increase access to therapeutic shoes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- UCSF Stanyan Hospital Podiatry Residency Program, San Francisco, CA 94117, USA.
- Dr. William M. Scholl College of Podiatric Medicine's Center for Lower Extremity Ambulatory Research (CLEAR) at Rosalind Franklin University, North Chicago, IL 60064, USA.
ORCID-Profile: Ryan Thomas Crews
Förderung
- American Podiatric Medical Association
- American Podiatric Medical Student Association
Zitieren
APA
Kurth, C. S., & Crews, R. T. (2026). Healthcare Provider Knowledge and Utilization of the Medicare Therapeutic Shoe Benefit. Journal of the American Podiatric Medical Association, 116(3), 32. https://doi.org/10.3390/japma116030032
Vancouver
Kurth CS, Crews RT. Healthcare Provider Knowledge and Utilization of the Medicare Therapeutic Shoe Benefit. Journal of the American Podiatric Medical Association. 2026;116(3):32. doi:10.3390/japma116030032
BibTeX
@article{Kurth2026,
author = {Kurth, Carol Szmuilowicz and Crews, Ryan Thomas},
title = {Healthcare Provider Knowledge and Utilization of the Medicare Therapeutic Shoe Benefit},
journal = {Journal of the American Podiatric Medical Association},
year = {2026},
volume = {116},
number = {3},
pages = {32},
doi = {10.3390/japma116030032}
}
EUVIMED